Hi @nanay , could you respond to @Utsikt 's posts, please?Then you probably won’t mind addressing my previous comments regarding commercialisation of the app through a health tech startup?
@nanay - would you be able to elaborate on the this from your website?
Edinburgh Venture Builder
If this is this programme,Enterprise and venture support linked to the University of Edinburgh.
How does that align with this previous statement of yours:Venture Builder Incubator is designed for ambitious postgraduate students, early career researchers and academics who are looking to transform their deep tech or data-driven research into a viable business.
Finally, I think it’s important to emphasise context: this is early-stage...
To clarify,
So you’re doing patient involvement, but this has nothing to do with medicine at all?The mention of the Edinburgh Venture Builder incubator on the website relates to a small amount of support we received to facilitate early user engagement and design work, specifically around PPIE activities and shaping the user-facing aspects of the app.
It’a irrelevant what it’s currently being positioned as.The support is not tied to commercialisation, nor does it mean the project is being actively positioned as a startup product.
So there is still a plan to commercialise it at some point (assuming it works)?The programme was referenced on the website simply for transparency around the type of support we’ve accessed, rather than to suggest that FatigueSense is currently being commercialised.
What’s a digital biomarker please?The mention of the Edinburgh Venture Builder incubator on the website relates to a small amount of support we received to facilitate early user engagement and design work, specifically around PPIE activities and shaping the user-facing aspects of the app.
The support is not tied to commercialisation, nor does it mean the project is being actively positioned as a startup product. The work we’re doing remains very much early-stage and research-led, focused on understanding fatigue, user needs, and how digital biomarkers might be meaningfully applied in practice.
The programme was referenced on the website simply for transparency around the type of support we’ve accessed, rather than to suggest that FatigueSense is currently being commercialised.
Thank you for the feedback .Thank you for continuing to engage with us, @nanay. Of course I accept that this s a beta app in development and not intended as medical advice etc etc. That's partly why I felt it worth my while to participate in testing it, as I'm experienced enough and confident enough with pacing to be sure I wouldn't fall into the trap of following bad advice, so it was safe for my health to test it.
My problem with it is the whole premise on which the output to clients is based seems to be to give advice, not just analysis of data in a clear form for patients to interpret for themselves. While you persevere in using AI to write feedback, and providing activity plans it will continue to be completely inappropriate for sick people, in particular ones whose health depends on them not listening to advice on how much activity to do, but rather on learning to interpret the 'data' they receive from current symptoms, not just day by day, but minute by minute.
For example, today the app told me to do activities in 20 minute sessions and that light walking is fine. If I followed either of those pieces of advice, I know from experience I would crash badly and probably be very much sicker for days or weeks. And crashing in ME/CFS means PEM from which I may never return to baseline. It's simply too risky for an app, however clever, to provide advice for people with ME/CFS.
However the model refines such advice according to what I feed in and what my app provides, that will never be appropriate for me, as I need to gauge all the time whether I need to stop an activity and take a break and for how long depending on my symptoms.
I think a major mistake with this app is assuming fatigue and the person's perceived energy are the key features to be recorded and used for planning. They are not. OI, pain, physical and cognitive fatigability, nausea, flu like malaise and other symptoms all feed into the signals I get from my body.
People with ME/CFS are desperate to find ways to make our lives more managable, and the promising features of this app of being able to automatically feed in data from wearables we already own makes it an attractive sounding proposition. That will draw people in and those less clued up by experience and examination of research evidence and shared experiences as we have here may fall into the trap of thinking the app is providing medically valid advice, regardless of any disclaimers. That is a serious risk which would make the development of this app into a commercial or clinical product unethical if it continues its current approach of using AI and providing plans and advice for people to follow.
What’s a digital biomarker please?
So you’re doing patient involvement, but this has nothing to do with medicine at all?
It’a irrelevant what it’s currently being positioned as.
To be clear: do you have any financial ties to this company? Employment, ownership, stocks, options, etc.?
If so, why was that not disclosed in the publications?
So there is still a plan to commercialise it at some point (assuming it works)?
You have clearly not shared all relevant information. All conflicts of interests related to the scientific publications have to be disclosed as a matter of policy by Frontiers.Thanks for the questions. We’ve shared all relevant information publicly in our materials and aren’t able to expand further in a forum setting.
You have gone from saying that this is purely for research purposes in the start of the thread, to saying that’s it not currently being commercialised. On your profile, there’s talk about a health tech startup, which is obviously commercial.The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
That’s a confusing nameA digital biomarker is simply a measurable signal from a device that reflects a person’s physical state. For example, data from wearables like Fitbit, Garmin, or Apple Watch such as heart rate, steps, sleep, and activity levels.
Just to add to this comment, I think a lot of people, including healthcare professionals and researchers, don't realize how many different symptoms people with ME/CFS get, especially after any exertion.'Fatigue' when used as a term to describe an aspect of some physical diseases is a completely different thing from physically healthy fatigue, and can't be fixed by the same methods of getting more sleep, relaxing, getting more exercise and so on. It's not a lifestyle problem, it's symptom of illness. In the case of ME/CFS it's not, for many of us, the most disabling symptom.
Funny video!
Do you want to share it here? If not, can you just list a few points you raised. I'm interested to know if we found the same issues.I have sent in my feedback to the app developers and deleted it as well.